Type 2 Diabetes Mellitus

Nursing Clinics of North America

Volumn 41, Issue 4, 2006, Pages 531-547

  Skelly, Anne H ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; MASS SCREENING; METABOLIC SYNDROME X; NOMENCLATURE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR;

DIABETES MELLITUS, TYPE 2; HUMANS; MASS SCREENING; METABOLIC SYNDROME X; RISK FACTORS; TERMINOLOGY; TERMINOLOGY AS TOPIC;

EID: 33750070321     PISSN: 00296465     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cnur.2006.07.011     Document Type: Review

References (36)

1. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20 (1997) 1183
2. Mokdad A.H., Ford E.S., Bowman B.A., et al. Diabetes trends in the US 1990-1998. Diabetes Care 23 (2000) 1278
3. Burant CF, editor. Diagnosis and classification. In: Medical management of type 2 diabetes. 5th edition. Alexandria (VA): American Diabetes Association; 2004. p. 6.
4. Harris M.I., Klein R., Welborn T.A., et al. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 15 (1992) 815
5. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002) 393-403
6. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 27 Suppl 1 (2004) S5-S10
7. Harmel A, Mathur R, editors. Classification of diabetes mellitus. In: Davidson's diabetes mellitus. 5th edition. Philadelphia: WB Saunders; 2004. p. 10-7.
8. Freeman S. The metabolic syndrome: diagnosis and management. Women's Health Care 4 (2005) 11-30
9. Frayn K. Diabetes mellitus. In: Malden M.A. (Ed). Metabolic regulation: a human perspective. 2nd edition (2003), Blackwell Sciences, Malden (MA) 284-285
10. Kahn R., Buse J., Ferrannini E., et al. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28 (2005) 2289-2304
11. Alberti K.G.M.M., Zimmet P.Z., and for the WHO Consultation. Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetes Med 15 (1998) 539-553
12. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486
13. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Available at: www.idf.org/webdata/docs/Metac_syndrome_def.pdf. Accessed 2/12/06.
14. Einhorn D., Reaven G.M., Cobin R.H., et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 9 (2003) 237-252
15. Grundy S.M., Hansen B., Smith Jr. S.C., et al. Clinical management of the metabolic syndrome. Report of the American Heart Association/ National Heart, Lung, and Blood Institute/ American Diabetes Association conference on scientific issues related to management. Circulation 109 (2004) 551-556
16. Caprio S. Prediabetes and the metabolic syndrome in obese children. Cadre's Current Diabetes Practices 3 (2005) 7-8
17. American Diabetes Association. Standards of medical care in diabetes: 2006. Diabetes Care 29 Suppl 1 (2006) S4-S42
18. American Diabetes Association. Screening for type 2 diabetes (position statement). Diabetes Care 27 Suppl 1 (2004) S11-S14
19. Hattersley A. Genetic factors in the etiology of non-insulin-dependent diabetes. Front Horm Res 22 (1997) 157
20. Cotran R., Kumar V., and Collins T. The endocrine pancreas. Robbins' pathologic basis of disease. 6th edition (1999), WB Saunders, Philadelphia 911-929
21. Boden G. Pathogenesis of type 2 diabetes: insulin resistance. Endocrinol Metab Clin North Am 30 (2001) 801-815
22. Semenkovich C.F., and Heinecke J.W. The mystery of diabetes and atherosclerosis: time for a new plot. Diabetes 46 (1997) 327
23. Nathan D.M. The pathophysiology of diabetes complications: how much does the glucose hypothesis explain?. Ann Intern 124 (1996) 86
24. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
25. Vlassara H. Recent progress in advanced glycation end products and diabetic complications. Diabetes 46 Suppl 2 (1997) S19-S25
26. Matz R. Hyperosmolar nonacidotic diabetes. In: Porte D.J., and Sherwin R.S. (Eds). Ellenberg & Rifkin's diabetes mellitus. 5th edition (1997), Appleton & Lange, Stamford (CT) 845
27. Funnell M., and Kruger D. Type 2 diabetes: treat to target. Nurse Pract 29 (2004) 11-15 19-23
28. Franz M, editor. A core curriculum for diabetes education. 4th edition. Chicago: American Association of Diabetes Educators, 2001.
29. Mensing C., Boucher J., Cypress M., et al. National standards for diabetes self-management education. Diabetes Care 29 (2006) S78-S85
30. Rizvi A. Type 2 diabetes: epidemiologic trends, evolving pathogenic concepts, and recent changes in therapeutic approach. South Med J 97 (2004) 1079-1087
31. Pinhas-Hamiel O., and Zeitler P. Barriers to the treatment of adolescent type 2 diabetes: a survey of provider perceptions. Pediatr Diabetes 4 (2003) 24-28
32. Motil K. Dietary history and recommended dietary intake in children. Available at: http://www.uptodate.com. Accessed April 13, 2005.
33. Zuhri-Yafi M., Brosnan P.G., and Hardin D.S. Treatment of type 2 diabetes in children and adolescents. J Pediatr Endocrinol Metab 15 (2002) 541-546
34. McKnight-Menci H., Sababu S., and Kelly S.D. The care of children and adolescents with type 2 diabetes. J Pediatr Nurs 20 (2005) 96-106
35. Kahn S. The case for aggressive treatment before and after diagnosis in type 2 diabetes. Cadre's Current Diabetes Practices 3 (2004) 1-2
36. Gaede P., Vedel P., Larsen N., et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348 (2003) 383-393